Skip to main content

Lichen Sclerosus clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Showing trials for
  • Ruxolitinib Cream in Participants With Lichen Sclerosus

    Sorry, in progress, not accepting new patients

    The purpose of this study is to evaluate the efficacy and safety of Ruxolitinib cream in participants With Lichen Sclerosus. This is randomized, double-blind, vehicle-controlled (DBVC) study with a DBVC period of 12 weeks followed by an open label period (OLE) period of 12 weeks.

    Irvine, California and other locations

Last updated: